Gregory Cairncross
Gregory Cairncross
Professor of Clinical Neurosciences, University of Calgary
Dirección de correo verificada de
Citado por
Citado por
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp, WP Mason, MJ Van Den Bent, M Weller, B Fisher, ...
New England journal of medicine 352 (10), 987-996, 2005
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
ME Hegi, AC Diserens, T Gorlia, MF Hamou, N De Tribolet, M Weller, ...
New England Journal of Medicine 352 (10), 997-1003, 2005
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the …
R Stupp, ME Hegi, WP Mason, MJ Van Den Bent, MJB Taphoorn, ...
The lancet oncology 10 (5), 459-466, 2009
Response criteria for phase II studies of supratentorial malignant glioma.
DR Macdonald, TL Cascino, SC Schold Jr, JG Cairncross
Journal of clinical oncology 8 (7), 1277-1280, 1990
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas
JG Cairncross, K Ueki, MC Zlatescu, DK Lisle, DM Finkelstein, ...
JNCI: Journal of the National Cancer Institute 90 (19), 1473-1479, 1998
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402
G Cairncross, M Wang, E Shaw, R Jenkins, D Brachman, J Buckner, ...
Journal of clinical oncology 31 (3), 337, 2013
Gene expression-based classification of malignant gliomas correlates better with survival than histological classification
CL Nutt, DR Mani, RA Betensky, P Tamayo, JG Cairncross, C Ladd, ...
Cancer research 63 (7), 1602-1607, 2003
Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED] Report of the Quality Standards Subcommittee of the American Academy of …
MJ Glantz, BF Cole, PA Forsyth, LD Recht, PY Wen, MC Chamberlain, ...
Neurology 54 (10), 1886-1893, 2000
Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial
W Roa, PMA Brasher, G Bauman, M Anthes, E Bruera, A Chan, B Fisher, ...
Journal of clinical oncology 22 (9), 1583-1588, 2004
Short-course radiation plus temozolomide in elderly patients with glioblastoma
JR Perry, N Laperriere, CJ O’Callaghan, AA Brandes, J Menten, C Phillips, ...
New England Journal of Medicine 376 (11), 1027-1037, 2017
European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Effects of …
R Stupp, ME Hegi, WP Mason, MJ van den Bent, MJ Taphoorn, ...
Lancet Oncol 10 (5), 459-466, 2009
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group …
G Cairncross, B Berkey, E Shaw, R Jenkins, B Scheithauer, D Brachman, ...
J Clin Oncol 24 (18), 2707-2714, 2006
Stem cell–related “self-renewal” signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma
A Murat, E Migliavacca, T Gorlia, WL Lambiv, T Shay, MF Hamou, ...
Journal of clinical oncology 26 (18), 3015-3024, 2008
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE. 3
T Gorlia, MJ van den Bent, ME Hegi, RO Mirimanoff, M Weller, ...
The lancet oncology 9 (1), 29-38, 2008
Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review
N Laperriere, L Zuraw, G Cairncross, ...
Radiotherapy and Oncology 64 (3), 259-273, 2002
Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial
RO Mirimanoff, T Gorlia, W Mason, MJ Van den Bent, RD Kortmann, ...
J Clin Oncol 24 (16), 2563-2569, 2006
Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis
Y Ino, RA Betensky, MC Zlatescu, H Sasaki, DR Macdonald, ...
Clinical Cancer Research 7 (4), 839-845, 2001
Radation therapy for brain metastases
JG Cairncross, JH Kim, JB Posner
Annals of Neurology: Official Journal of the American Neurological …, 1980
Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.
G Cairncross, D Macdonald, S Ludwin, D Lee, T Cascino, J Buckner, ...
Journal of Clinical Oncology 12 (10), 2013-2021, 1994
Changing paradigms—an update on the multidisciplinary management of malignant glioma
R Stupp, ME Hegi, MJ Van Den Bent, WP Mason, M Weller, ...
The oncologist 11 (2), 165-180, 2006
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20